9 dicembre 2020 – The pharmaceutical company Janssen-Cilag, which is part of the Johnson & Johnson Group, submitted an application to Swissmedic to have its vaccine candidate Ad26.COV2.S authorised. Swissmedic is examining Janssen’s COVID-19 vaccine in a rolling submission procedure.

For further information, see here.